Oramed Pharmaceuticals Inc. (ORMP) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Oramed Pharmaceuticals Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 1.57x | -5.17x | 16.86x | -12.42x | -25.19x | -6.23x |
| P/B Ratio | 0.59x | 0.68x | 0.57x | 3.09x | 4.84x | 2.18x |
| P/S Ratio | 59.00x | 0.00x | 69.50x | 173.56x | 207.28x | 26.44x |
| Profitability | ||||||
| Gross Margin | 0.7% | 0.0% | 100.0% | 100.0% | 100.0% | 96.7% |
| Operating Margin | -754.4% | 0.0% | -1176.8% | -1502.0% | -896.2% | -433.8% |
| Net Margin | 3766.2% | 0.0% | 412.3% | -1397.1% | -822.7% | -424.8% |
| EBITDA Margin | -754.4% | 0.0% | 546.3% | -1368.0% | -926.3% | -417.4% |
| Liquidity | ||||||
| Current Ratio | 6.98x | 25.19x | 3.06x | 27.34x | 14.27x | 8.93x |
| Quick Ratio | 6.98x | 25.19x | 3.06x | 27.34x | 14.27x | 8.93x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.32x | 0.01x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..